Sampling Considerations in Continuous Manufacturing

About the Author

Principal Scientist

Center for Mathematical Science in the Merck Manufacturing Division At Merck & C

Plinio A. De los Santos is a Principal Scientist at the Center for Mathematical Science in the Merck Manufacturing Division at Merck & Co., Inc...

Jeffrey Hofer

Sr Research Advisor, Global Statistical Sciences

Eli Lilly & Co Mfg & Quality Learning Ctr

Mr. Hofer is a Senior Research Advisor in the Global Statistical Sciences team at Eli Lilly. He received a B.S. in Applied Statistics from the...

Eric Jayjock, PhD

CONTINUUS Pharmaceuticals

Eric Jayjock performed his graduate studies at Rutgers University where he was a part of the NSF Center for Structured Organic Particulate (C-SOPS) systems. During...

Tim Kramer

Sr. Research Advisor

Eli Lilly and Company

Timothy T. Kramer is Senior Research Advisor at Eli Lilly and Company. He joined Lilly in 2007 and has supported the development of many small...

Kevin Lief

Martin Otava

Principal Statistician in Quantitative Sciences

Janssen Pharmaceutical (J&J)

Martin Otava, is a Principal Statistician in Quantitative Sciences of Janssen Pharmaceutical Companies of Johnson & Johnson. He provides statistical support to research and development...

Technical

Selection Criteria for Pharmaceutical Containment Equipment

1 March 2024

Pharmaceutical manufacturing facilities produce a variety of products, including highly potent products that require safety measures to prevent adverse health effects on patients and operators. To ensure safety, these facilities use containment equipment to minimize the risk of contamination. This article presents criteria for selecting containment equipment, considering both...

Technical

A Sustainable Approach to Steam Quality Management

1 March 2024

The world is beginning to grasp the huge challenge of achieving net-zero carbon emissions, or carbon neutrality, by 2050. Many countries have committed to achieving this ambitious goal. As a major global industry, the pharmaceutical sector has a significant role to play. For thermal energy–intensive industries, such as pharmaceutical manufacturing, the long-term future options to maintain...

Technical

Concluding Compliance Challenges with Validation 4.0

13 March 2024

As the pharma industry moves to an ambitious Validation 4.0 paradigm, computerized systems play a pivotal role in enabling the rapid transition. Innovation and agility in computerized system validation (CSV) received a strong push in the second half of 2022 with the publication of the FDA draft guidance on “Computer Software Assurance for Production and Quality System Software”

About the Author

Facilities of the Future: Meeting the Demands of Breakthrough Therapeutics

Emerging Leader Hacker to GAMPer in 10 Weeks

New Initiative Seeks to Back up ICHs Harmonization Mission

Data Science-Assisted Biopharmaceutical Tech Transfer and Process Characterization

Entering a New Era of Innovation and Collaboration With the Focus on the Workforce of the Future

Q&A with ISPE Foundation Professional Development Grant Recipient Silas Tamufor

Related Articles